Latin America Reporter
SEE OTHER BRANDS

The latest news from Latin America

Latin America Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Reporter.

Press releases published on April 28, 2025

Modern Heart and Vascular Institute Opens New Clinic in Spring, Texas

Modern Heart and Vascular Institute Opens New Clinic in Spring, Texas

Modern Heart and Vascular Institute, Cardiology Practice, Opens New Clinic in Spring, Texas SPRING, TX, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- Modern Heart and Vascular Institute has announced the opening of its newest clinic in Spring, …

Trucent Renewable Chemicals Secures TruFA® Trademark

Trucent Renewable Chemicals Secures TruFA® Trademark

TruFA® is now a registered trademark—offering a certified, spec-ready alternative to TOFA that’s domestically sourced and U.S. produced. VAN WERT, OH, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- Trucent Renewable Chemicals Secures TruFA® …

O Chamado a um Guia Livre e Universal

O Chamado a um Guia Livre e Universal

A N.Y. Climate Week segue o caminho deixado pelo Papa Francisco. Trabalha-se aguardando o novo Pontífice "da cooperação". ROMA, ITALY, April 28, 2025 /⁨EINPresswire.com⁩/ -- Em uma época marcada pelo desconcerto, rápidas transformações e um crescente …

U.S. Amputee Soccer Names 2026 World Cup Qualifiers Roster, Launches Fundraiser for Mexico

U.S. Amputee Soccer Names 2026 World Cup Qualifiers Roster, Launches Fundraiser for Mexico

STONY BROOK, NY, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- The American Amputee Soccer Association is proud to announce the official roster of players who will represent the United States in the 2026 Amputee Soccer World Cup Qualifiers, to be …

NovaCHARGE and Charge Rigs to Showcase the FLEXX Mobile DC Fast Charger Line at ACT Expo 2025

NovaCHARGE and Charge Rigs to Showcase the FLEXX Mobile DC Fast Charger Line at ACT Expo 2025

Innovative, All-Electric Mobile Charging Series Returns to the Spotlight at Booth #5827 ORLANDO, FL, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- NovaCHARGE, a leader in electric vehicle (EV) charging technology, is proud to announce the feature …

OROCO FILES SHELF PROSPECTUS

OROCO FILES SHELF PROSPECTUS

Vancouver, Canada, April 28, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”).  is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the “Prospectus“) …

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a …

Grupo Bafar Reports First Quarter 2025 Results

Grupo Bafar Reports First Quarter 2025 Results

CHIHUAHUA, Mexico, April 28, 2025 (GLOBE NEWSWIRE) -- Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading and benchmark company in the national food sector, announced its results for the first quarter of 2025, highlighting sustained growth driven by …

Houston's Baker energy consultancy critiques post-Macondo safety of  a decade later

Houston's Baker energy consultancy critiques post-Macondo safety of a decade later

During the decade following the Macondo disaster that unfolded on April 20, 2010, there was a global reassessment of offshore safety, focused on U.S. waters HOUSTON, TX, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- In its 20th report on the …

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …

Oxbridge / SurancePlus to Speak during TOKEN2049 Dubai at Tokenized Capital Summit 2025 and at THE GREAT GATHER - Day 2

Oxbridge / SurancePlus to Speak during TOKEN2049 Dubai at Tokenized Capital Summit 2025 and at THE GREAT GATHER - Day 2

GRAND CAYMAN, Cayman Islands, April 28, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene expression Interim safety data including patient demographic data from all SAD cohorts of the first-in-human Phase …

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils …

SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024

SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH), today reported audited financial results for the fiscal year ended December 31, 2024. Financial Highlights for the Year Ended December 31, 2024 Total …

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

Terra Balcanica annonce un placement fondé sur la dispense pour financement de l’émetteur coté

NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 28 avr. 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) a le …

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

NEW HOPE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today …

Transocean Ltd. Reports First Quarter 2025 Results

Transocean Ltd. Reports First Quarter 2025 Results

  Three months ended         Three months ended         March 31,   December 31,   sequential   March 31,   year-over-year   2025   2024   change   2024   change (In millions, except per share amounts, percentages and backlog)                             …

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service